Plumbagin inhibits the proliferation and survival of esophageal cancer cells by blocking STAT3-PLK1-AKT signaling

Esophageal squamous cell carcinoma (ESCC) is one of the deadliest cancers, and it requires novel treatment approaches and effective drugs. In the present study, we found that treatment with plumbagin, a natural compound, reduced proliferation and survival of the KYSE150 and KYSE450 ESCC cell lines i...

Descripción completa

Detalles Bibliográficos
Autores principales: Cao, Ying-Ya, Yu, Jing, Liu, Ting-Ting, Yang, Kai-Xia, Yang, Li-Yan, Chen, Qun, Shi, Feng, Hao, Jia-Jie, Cai, Yan, Wang, Ming-Rong, Lu, Wei-Hua, Zhang, Yu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5833725/
https://www.ncbi.nlm.nih.gov/pubmed/29339720
http://dx.doi.org/10.1038/s41419-017-0068-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5833725/
https://www.ncbi.nlm.nih.gov/pubmed/29339720
http://dx.doi.org/10.1038/s41419-017-0068-6

Ejemplares similares